CXCL2
CXCL2 (C-X-C motif chemokine ligand 2, also known as GROb, MIP-2a, MGSA-b, CINC-2a, GRO2 and SCYB2) is a secreted CXC chemokine produced by activated monocytes and neutrophils. It is expressed at sites of inflammation and has haematoregulatory activity. Browse Assay Genie's current range of CXCL2 research reagents below, or read on for the biology behind the target.
CXCL2 is a haematoregulatory chemokine. It is produced by activated monocytes and neutrophils and is expressed at sites of inflammation. In vitro, it suppresses the proliferation of haematopoietic progenitor cells, and the NCBI Gene summary notes that it may have this role more generally. A processed form, GRO-beta(5-73), shows a highly enhanced haematopoietic activity, so the form of the protein matters when interpreting results.
The CXCL2 gene belongs to a chemokine superfamily that encodes secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies according to the arrangement of the N-terminal cysteine residues of the mature peptide. CXCL2 is a member of the CXC subfamily and, in UniProt, of the intercrine alpha (chemokine CxC) family. NCBI Gene describes the gene as antimicrobial. The mature protein is secreted. Mouse and rat both carry a Cxcl2 ortholog, which allows comparative work in rodent models.
The protein has several names in the literature: GRO-beta, GROb, MIP-2a, MGSA-b and CINC-2a. The HGNC previous symbols and names include SCYB2, GRO2, "GRO2 oncogene" and "chemokine (C-X-C motif) ligand 2". HGNC places it in the chemokine ligands gene group, alongside other CXC ligands such as CXCL1 and CXCL3. Researchers studying CXCL2 often use an anti-CXCL2 antibody or a CXCL2 ELISA kit to follow its expression in inflammatory settings.
CXCL2 is expressed at sites of inflammation and is involved in immunoregulatory and inflammatory processes, making it a relevant marker of inflammatory activity.
The chemokine is produced by activated monocytes and neutrophils, so it is used to study how these innate immune cells respond to activation.
CXCL2 suppresses haematopoietic progenitor cell proliferation in vitro, and the GRO-beta(5-73) form shows enhanced haematopoietic activity.
As a CXC subfamily member in the intercrine alpha family, CXCL2 is studied alongside related ligands to compare chemokine roles.
CXCL2 is a secreted chemokine made by activated monocytes and neutrophils and expressed at sites of inflammation. It acts as a haematoregulatory chemokine and, in vitro, suppresses haematopoietic progenitor cell proliferation. The processed GRO-beta(5-73) form shows highly enhanced haematopoietic activity.
CXCL2 is also called GRO-beta, GROb, MIP-2a, MGSA-b, CINC-2a and GRO2. Earlier HGNC symbols and names include SCYB2, "GRO2 oncogene" and "chemokine (C-X-C motif) ligand 2". The UniProt entry is named C-X-C motif chemokine 2.
Mouse and rat each have a Cxcl2 ortholog, so the protein can be studied in rodent models. Human CXCL2 belongs to the CXC subfamily of chemokines. Check the datasheet of any product for its validated reactivity.
Other CXC chemokine ligands involved in inflammatory and immunoregulatory processes, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P19875; product specifications from Assay Genie datasheets.